Neoadjuvante Therapieschemen kombiniert mit adjuvanter Therapie bei muskelinvasivem Blasenkrebs vor bzwnach radikaler Zystektomie

Translated title of the contribution: Neoadjuvant therapy schemes combined with adjuvant therapy in muscle-invasive bladder cancer before and after radical cystectomy, respectively: A randomized, open, multicenter, global phase III trial to determine the efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for the neoadjuvant treatment, followed by durvalumab only for the adjuvant treatment in patients with muscle-invasive bladder cancer (NIAGARA) - AB 74/20 of the AUO

Heidrun Rexer, Hubert Kübler, Margitta Retz

Research output: Contribution to journalComment/debate

Translated title of the contributionNeoadjuvant therapy schemes combined with adjuvant therapy in muscle-invasive bladder cancer before and after radical cystectomy, respectively: A randomized, open, multicenter, global phase III trial to determine the efficacy and safety of durvalumab in combination with gemcitabine+cisplatin (G+C) for the neoadjuvant treatment, followed by durvalumab only for the adjuvant treatment in patients with muscle-invasive bladder cancer (NIAGARA) - AB 74/20 of the AUO
Original languageGerman
Pages (from-to)220-221
Number of pages2
JournalAktuelle Urologie
Volume52
Issue number3
DOIs
StatePublished - 1 Jun 2021
Externally publishedYes

Cite this